Showing results (281-290 of 431) with videos related to

Sort By:
Pageof 44
Trials|February 11, 2023
The Michigan Genetic Hereditary Testing (MiGHT) study's innovative approaches to promote uptake of clinical genetic testing among cancer patients: a study protocol for a 3-arm randomized controlled trialLynette Hammond Gerido, Jennifer J Griggs, Ken Resnicow, et al.
Clinical Pharmacology and Therapeutics|July 4, 2006
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatmentSilvana Borges, Zeruesenay Desta, Lang Li, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 1, 2022
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptomsDaniel L Hertz, Julie A Douglas, Robert M Miller, et al.
Breast Cancer Research and Treatment|January 21, 2009
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohortN Lynn Henry, James M Rae, Lang Li, et al.
Breast Cancer Research and Treatment|September 13, 2005
Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapyAnne F Schott, Marilyn A Roubidoux, Mark A Helvie, et al.
Pharmacogenomics|July 24, 2020
Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathyYongzhen Chen, Fang Fang, Kelley M Kidwell, et al.
Breast Cancer Research and Treatment|February 13, 2019
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletionLandry K Kamdem, Jingyue Xi, Brandi L Clark, et al.
Pharmacogenomics|June 14, 2019
Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozoleJacqueline M Dempsey, Kelley M Kidwell, Christina L Gersch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2016
Maternal Embryonic Leucine Zipper Kinase (MELK) as a Novel Mediator and Biomarker of Radioresistance in Human Breast CancerCorey Speers, Shuang G Zhao, Vishal Kothari, et al.
Molecular Oncology|March 30, 2013
Monitoring apoptosis and Bcl-2 on circulating tumor cells in patients with metastatic breast cancerJeffrey B Smerage, G Thomas Budd, Gerald V Doyle, et al.
Pageof 44